Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2017 $ 12,162 $ 48 $ 109,708 $ (97,595) $ 1
Beginning balance, Shares at Dec. 31, 2017   9,827,129      
Exercise of stock options 343 $ 3 340    
Exercise of stock options, Shares   486,588      
Issuance of common stock in connection with exercise of warrants, shares   16,129      
Stock-based compensation 427   427    
Other comprehensive income (loss) 29       29
Cumulative effect of change in accounting principle 3,025     3,025  
Net income (loss) (1,217)     (1,217)  
Ending balance at Mar. 31, 2018 14,769 $ 51 110,475 (95,787) 30
Ending balance, Shares at Mar. 31, 2018   10,329,846      
Beginning balance at Dec. 31, 2017 12,162 $ 48 109,708 (97,595) 1
Beginning balance, Shares at Dec. 31, 2017   9,827,129      
Net income (loss) (1,586)        
Ending balance at Jun. 30, 2018 16,433 $ 53 112,639 (96,156) (103)
Ending balance, Shares at Jun. 30, 2018   10,759,719      
Beginning balance at Mar. 31, 2018 14,769 $ 51 110,475 (95,787) 30
Beginning balance, Shares at Mar. 31, 2018   10,329,846      
Exercise of stock options 108   108    
Exercise of stock options, Shares   66,628      
Issuance of common stock in connection with exercise of warrants 989 $ 1 988    
Issuance of common stock in connection with exercise of warrants, shares   272,309      
Issuance of common stock from ESPP purchase 421 $ 1 420    
Issuance of common stock from ESPP purchase, Shares   43,624      
Issuance of common stock from RSUs vested, shares   47,312      
Stock-based compensation 648   648    
Other comprehensive income (loss) (133)       (133)
Net income (loss) (369)     (369)  
Ending balance at Jun. 30, 2018 16,433 $ 53 112,639 (96,156) (103)
Ending balance, Shares at Jun. 30, 2018   10,759,719      
Beginning balance at Dec. 31, 2018 17,147 $ 55 114,618 (97,377) (149)
Beginning balance, Shares at Dec. 31, 2018   10,864,722      
Exercise of stock options 219 $ 1 218    
Exercise of stock options, Shares   177,408      
Issuance of common stock upon secondary offering, net of costs 10,554 $ 1 10,553    
Issuance of common stock upon secondary offering net of costs, Shares   250,000      
Issuance of common stock from RSUs vested, shares   28,790      
Stock-based compensation 754   754    
Other comprehensive income (loss) (13)       (13)
Net income (loss) (362)     (362)  
Ending balance at Mar. 31, 2019 28,299 $ 57 126,143 (97,739) (162)
Ending balance, Shares at Mar. 31, 2019   11,320,920      
Beginning balance at Dec. 31, 2018 17,147 $ 55 114,618 (97,377) (149)
Beginning balance, Shares at Dec. 31, 2018   10,864,722      
Net income (loss) 25        
Ending balance at Jun. 30, 2019 30,448 $ 57 127,870 (97,352) (127)
Ending balance, Shares at Jun. 30, 2019   11,476,685      
Beginning balance at Mar. 31, 2019 28,299 $ 57 126,143 (97,739) (162)
Beginning balance, Shares at Mar. 31, 2019   11,320,920      
Exercise of stock options 129   129    
Exercise of stock options, Shares   65,960      
Issuance of common stock in connection with exercise of warrants 51   51    
Issuance of common stock in connection with exercise of warrants, shares   12,225      
Issuance of common stock from ESPP purchase 642   642    
Issuance of common stock from ESPP purchase, Shares   53,508      
Issuance of common stock from RSUs vested, shares   24,072      
Stock-based compensation 905   905    
Other comprehensive income (loss) 35       35
Net income (loss) 387     387  
Ending balance at Jun. 30, 2019 $ 30,448 $ 57 $ 127,870 $ (97,352) $ (127)
Ending balance, Shares at Jun. 30, 2019   11,476,685